Home > Boards > US Listed > Biotechs > Vascular Biogenics Ltd. (VBLT)

Another slow day..

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Dennisb68 Member Profile
Member Level 
Followed By 119
Posts 27,475
Boards Moderated 4
Alias Born 02/03/05
160x600 placeholder
VET, TCOM, TTM and ZI among premarket gainers Seeking Alpha - 2/23/2021 8:18:53 AM
VBL Therapeutics gets green light for VB-111 study in ovarian cancer, shares up 16% Seeking Alpha - 2/22/2021 7:32:38 AM
VBL Therapeutics Announces Data Safety Monitoring Committee Provides Green Light to Advance the OVAL Phase 3 Registration Ena... GlobeNewswire Inc. - 2/22/2021 7:00:00 AM
VBL Therapeutics Treats First Patient in Phase 2 Randomized Controlled Study of VB-201 in COVID-19 Patients GlobeNewswire Inc. - 1/27/2021 7:00:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 1/15/2021 7:05:09 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/15/2021 7:03:58 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 1/11/2021 6:02:46 AM
Securities Registration (foreign Private Issuer) (f-3) Edgar (US Regulatory) - 12/30/2020 4:17:39 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/24/2020 4:51:30 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/16/2020 7:18:35 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/16/2020 7:03:18 AM
VBL Therapeutics to Report Third Quarter 2020 Financial Results on November 16 GlobeNewswire Inc. - 11/2/2020 7:00:10 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 10/29/2020 9:01:19 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 10/19/2020 4:10:50 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 10/13/2020 8:31:06 AM
VBL Therapeutics to Provide an Update on the OVAL Study Today at the H. C. Wainwright 22nd Annual Global Investment Conferenc... GlobeNewswire Inc. - 9/15/2020 8:00:10 AM
VBL Presents Human Proof-of-Concept Data That Show the Potential of its Novel anti-MOSPD2 Monoclonal Antibodies for Multiple ... GlobeNewswire Inc. - 9/11/2020 8:00:10 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 8/26/2020 5:21:36 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/13/2020 7:01:01 AM
VBL Therapeutics Announces Second Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 8/13/2020 7:00:10 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/12/2020 8:46:07 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 8/5/2020 4:33:05 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 8/3/2020 8:39:54 AM
VBL Therapeutics to Report Second Quarter 2020 Financial Results on August 13 GlobeNewswire Inc. - 8/3/2020 8:00:10 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 7/31/2020 6:29:30 AM
Dennisb68 Member Level  Wednesday, 09/19/18 10:34:46 AM
Re: None
Post # of 2011 
Another slow day..

Remember that when someone tries to convince you to buy or sell there is something in it for them. It's not because they are concerned about your investment.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences